 |
|
|
| |
Safety and efficacy of darunavir/ritonavir in treatment-experienced pediatric patients aged 3 to <6 years: Week 48 analysis of the ARIEL trial
|
| |
| |
Reported by Jules Levin
IAS 2013 June 30-July 3 Kuala Lumpur
Avy Violari,1 Rosa Bologna,2 Nagalingeswaran Kumarasamy,3
Jose Henrique Pilotto,4 Annemie Hendrickx,5 Thomas N Kakuda,6
Erkki Lathouwers,5 Magda Opsomer,5 Tom Van de Casteele5 and
Frank L Tomaka6
1Chris Hani Baragwanath Hospital, Johannesburg, South Africa; 2Helios Salud, Buenos Aires, Argentina; 3YRGCARE Medical Centre, VHS, Chennai, India; 4Hospital Geral De Nova Iguacu,
Rio De Janeiro, Brazil; 5Janssen Infectious Diseases BVBA, Beerse, Belgium;
6Janssen Research & Development LLC, Titusville, NJ, USA
|
| |
|
|
|
|
|
